Monthly Prescribing Reference1d
Updated Sublocade Label Includes Rapid Induction, Alternative Injection Sites
Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.
A sip instead of a shot: Breast milk nanoparticle permeability phenomena discovered
Imagine if antibodies, proteins such as insulin, or even COVID-19 and flu vaccines could be consumed orally instead of via ...
Healio2d
FDA approves rapid initiation of Sublocade for opioid use disorder
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
Indivior Gets FDA Approval for Faster Initiation of Opioid-Dependence Treatment, More Injection Options
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.